Brand / Product	Market	Holder	Status	Expires
PALBOCARE 125 Capsule, Hard	🇰🇪Kenya	Javia International Limited	active	Mar 2031
PALCLIB 125 Capsule	🇰🇪Kenya	MSN LABORATORIES PRIVATE LIMITED (Formulation…	active	Jan 2031
PALCLIB 100 Capsule	🇰🇪Kenya	MSN LABORATORIES PRIVATE LIMITED (Formulation…	active	Jan 2031
PALBIS 100 Capsule	🇰🇪Kenya	M/s. Hetero Labs Limited	active	Jan 2031
PALBIS 125 Capsule	🇰🇪Kenya	M/s. Hetero Labs Limited	active	Jan 2031
Ibrance 100 mg Tablets Tablet	🇰🇪Kenya	Pfizer Laboratories Limited, Kenya	active	Jul 2030
Ibrance 75 mg Tablets Tablet	🇰🇪Kenya	Pfizer Laboratories Limited, Kenya	active	Jul 2030
Ibrance 125 mg Tablets Tablet	🇰🇪Kenya	Pfizer Laboratories Limited, Kenya	active	Jul 2030
PALBOCICLIB 125 mg TABLETS PFIZER	🇿🇦South Africa	Pfizer Laboratories (Pty) Ltd	active	Mar 2030
IBRANCE TABLETS 75 mg	🇿🇦South Africa	PFIZER LABORATORIES PFE (PTY) LTD	active	Mar 2030
IBRANCE TABLETS 100 mg	🇿🇦South Africa	Pfizer Laboratories (Pty) Ltd	active	Mar 2030
IBRANCE TABLETS 125 mg	🇿🇦South Africa	Pfizer Laboratories (Pty) Ltd	active	Mar 2030
PALBOCICLIB 75 mg TABLETS PFIZER	🇿🇦South Africa	Pfizer Laboratories (Pty) Ltd	active	Mar 2030
PALBOCICLIB 100 mg TABLETS PFIZER	🇿🇦South Africa	Pfizer Laboratories (Pty) Ltd	active	Mar 2030
Ibrance 75 mg Capsules** Capsule	🇳🇬Nigeria	Pfizer Specialties Ltd	active	Jul 2029
Ibrance 100 mg Capsules** Capsule	🇳🇬Nigeria	Pfizer Specialties Ltd	active	Jul 2029
Ibrance 125 mg Capsules** Capsule	🇳🇬Nigeria	Pfizer Specialties Ltd	active	Jul 2029
PALBOCICLIB PFIZER TABLET, COATED; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD, S.A	active	Nov 2028
IBRANCE TABLET, COATED; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD	active	Nov 2028
PALBOCICLIB PFIZER TABLET, COATED; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD	active	Nov 2028
PALBOCILIB PFIZER TABLET, COATED; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD, S.A	active	Nov 2028
IBRANCE TABLET, COATED; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD	active	Nov 2028
IBRANCE TABLET, COATED; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD	active	Nov 2028
PALBOCICLIB 125 mg CIPLA	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Feb 2028
IPALIB 75 mg	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Feb 2028
IPALIB 100 mg	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Feb 2028
IPALIB 125 mg	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Feb 2028
PALBOCICLIB 75 mg CIPLA	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Feb 2028
PALBOCICLIB 100 mg CIPLA	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Feb 2028
PALBOCICLIB PFIZER CAPSULE; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD	active	Dec 2027
PALBOCICLIB PFIZER CAPSULE; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD	active	Dec 2027
PALBOCICLIB PFIZER CAPSULE; ORAL	🇿🇼Zimbabwe	PFIZER LABORATORIES (PTY) LTD, S.A	active	Dec 2027
IBRANCE CAPSULES (Each capsule contains Palbociclib 75mg Palbociclib 75mg )	🇬🇭Ghana	—	expired	Jun 2026
IBRANCE CAPSULES ( Palbociclib 125mg)	🇬🇭Ghana	—	expired	Jun 2026
PALBIS 125MG GELULE BOITE DE 21	🇨🇮Côte d'Ivoire	HETERO LABS LIMITED	expired	Oct 2024
PALBIS 100MG GELULE BOITE DE 21	🇨🇮Côte d'Ivoire	HETERO LABS LIMITED	expired	Oct 2024
IBRANCE Gélule / 100MG	🇹🇳Tunisia	Pfizer Inc USA	expired	Jan 2021
IBRANCE Gélule / 75MG	🇹🇳Tunisia	Pfizer Inc USA	expired	Jan 2021
IBRANCE Gélule / 125MG	🇹🇳Tunisia	Pfizer Inc USA	expired	Jan 2021
Palbociclib Pfizer 125mg Oral tablet	🇹🇿Tanzania	Pfizer Laboratories Limited	active	—

PALBOCICLIB in Africa — Regulatory Overview

PALBOCICLIB is registered across 8 African markets with 40 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe, Kenya, Tunisia and 4 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 40 registrations, 33 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.